Clinicians may overestimate as well as underestimate how difficult a patient expects dose reduction to be.
The study paired questionnaires from 155 long-term benzodiazepine-treated patients with eight referring psychiatrists. Thirteen percent of patients anticipated more difficulty reducing treatment than their psychiatrist did; twenty-five percent anticipated less. Beliefs about symptoms and the treatment relationship were associated with discrepancies.
The cross-sectional questionnaire measured expectations, not completed tapers or withdrawal severity. The small clinician sample and long-term treatment setting limit generalization. Perceived difficulty cannot establish physiological dependence severity or future success.
For a care-plan review, examine whether the patient’s own preferences were elicited and recorded. Do not infer reluctance from a clinician’s assumption, or equate willingness with an absence of withdrawal risk. The study supports direct discussion rather than predictions based solely on medication duration.
Source: Publication PMC8214561. The case-review applications above are interpretive analysis.
Related reading: Clobazam-Shortage Review Found Wide Disagreement About Substitution.